Allergan: The Power Of Botox
Allergan (NYSE: AGN) announced its second quarter earnings and a dividend of $.05 a share. The company can afford it. Allergan made $242 million in net income on $1.27 billion in sales. The specialty…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 333Boston Scientific’s New Stent May Assist in Turnaround (BSX, ABT, JNJ, MDT, STJ)
Boston Scientific Corporation (NYSE: BSX) has been a long and painful investment for thousands of shareholders who have held shares in hopes that this turnaround stock can eventually turn around. News yesterday out of…
Today’s Best Market Rumors
Updated throughout the day. Genzyme (NASDAQ: GENZ) is considering an offer from Sanofi-Aventis (Reuters) Clayton Dubilier & Rice and Goldman Sachs’s private-equity unit are negotiating to buy Harrington Holdings (Bloomberg) Douglas A. McIntyre
Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)
Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the company. The WSJ reports that the large drug giant has approached what was the…
The Unusual Suspects for the Week Ahead (AAPL, BP, CROX, GE, GOOG, OREX, SWY, SD, VVUS, VOCL, CALL, VG)
This weekend’s edition of The Unusual Suspects includes mostly non-earnings events that will be on deck this coming week and/or some of the carry-over issues from last week. Our list of Unusual Suspects to…
Home Health Care Providers Under Scrutiny (LHCG, AMED, AFAM, GTIV)
Properly used, home health care can save billions of dollars annually in health care expenditures. Sending a patient home and then sending a professional nurse or therapist to visit them periodically is far cheaper…
GlaxoSmithKline: Another Drug Company Runs Afoul Of The Truth
GlaxoSmithKline (NYSE: GSK), like a number of pharmaceutical companies before it, has run up against the truth about one of its drugs. According to The New York Times, “In the fall of 1999, the…
National Employee Morale Day At Merck
Merck & Co., Inc. (NYSE: MRK) will dump 16,000 workers now that its merger with Schering-Plough well along. The company announced plans to phase out operations at eight research sites and eight manufacturing sites,…
BioHealth Business Daily (AMGN, SNY, AFFX, CORT, CRIS, CYTR, HGSI, NEXMD, NYMX, XNPT)
Today’s version of the BioHealth Business Daily is a very unusual lot of movers. Some moves are merely in sympathy and some are on news. We also have a re-review of Amgen Inc. (NASDAQ:…
More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)
Sanofi-Aventis SA (NYSE: SNY) was a bit of a stalking horse news item on a week that many investors and traders started taking off for a long weekend. The company has tried to telegraph…
This Month’s Biggest Index Losers: Radio, Chinese Advertising, and Cancer Treatment Stocks
Heavy losses were sustained in three Tickerspy indexes over the last 30-day period. This month’s biggest index losers are in radio, Chinese advertising, and cancer treatment stocks. Radio stocks are down 15.2% in the past…
Uncle Sam’s War Against PROVENGE Gets Nasty (DNDN)
If there is one single sector which could be immune to the crummy jobs data, it is biotech. Just don’t look at Dendreon Corporation (NASDAQ: DNDN) for much warmth today. There is not any…
BioHealth Business Daily (AMGN, AMLN, ALKS, DNDN, SNY, GENZ, MIPI)
There are many key movers in today’s BioHealth Business Daily. We have included background data, news, reactions, and added in color where applicable. BioHealth stocks to watch today are Amgen Inc. (NASDAQ: AMGN), Amylin…
Walgreen Vs. CVS Caremark: When Partnerships Turn South (WAG, CVS)
Sometimes little surprises are just as interesting as big ones. For example, Walgreen Co. (NYSE:WAG) has announced that it would not accept either new or renewal business from prescription drug plans administered by CVS…
BioHealth Business Daily (ARQL, APPY, BPAX, BMY, CLDX, CELG, DCTH, JAV, KERX, PCYC, TLCR, VVUS)
Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend. There are many other stocks…